Giving HOPE Sensory System accessing ears
Brenda Bates Medicine Woman demonstrates Sensory System Accessing healing tool. Use this the most when you see,hear, and so on them do it to you or act a certain way. Goes great with homeopathics - Giving HOPE Soul-pathic http://www.facebook.comFrom:Brenda MedicineWomanViews:0 0ratingsTime:01:58More inHowto Style
Read more:
Tech-Long Secondary Packaging System
TECH-LONG secondary packaging machine including: De/Palletizer, shrink wrapper, Case packer. Each series contain various products, which used in beer industry, beverage industry, food industry, chemical industry and medical industry etc. Tech-Long provides secondary packaging solution for the complete line or single equipment. Shrink Wrapper Packer Be widely used in beverage, beer, food and medicine, etc. Bottle Diameter: phi;56- phi;100 Packaging format: 23, 34, 44, 45, 46, 58, etc. Palletizer and Depalletizer Widely used for packages in beverage, beer, food, non-food glass, plastic bottles, medicine industry and 5-gallon water line. Max pallet dimension: 12501250150 mm Case Palletizer and Depalletizer Widely used for packages in beverage, beer, food, non-food glass, plastic bottles, medicine industry. Bottle Model: phi;55-100, 330ml-1.5L, H=230-330From:Amritraj BangeraViews:1 0ratingsTime:17:20More inScience Technology
Here is the original post:
Permanent Cure High Blood Pressure without take any Medicine-Swami Ramdev
This video effectively addresses problems arising out of high blood pressure. The essence of the pranayamas, yoga asanas, acupressure and home remedies for to cope with problems of high blood pressure is captured in this video. High blood pressure due to any reason - ie obesity, diabetes, renal (kidney) problems or hereditary causes - will get controlled with the essential practice of the various pranayams, asanas and home remedies that have been described in this video. Click:www.bharatswabhimantrust.org more Information Goto our website Connect with us on Facebook Page: http://www.facebook.com http://www.facebook.com Twitter :twitter.com twitter.com wiki :en.wikipedia.org Google +:plus.google.comFrom:TheBHARATSWABHIMANViews:1 2ratingsTime:09:00More inNonprofits Activism
More:
Permanent Cure High Blood Pressure without take any Medicine-Swami Ramdev - Video
Careers in clinical research
Careers in clinical research Clinical research is that branch of science which determines safety and effectiveness of medications, diagnostic products and treatment regimens intended for human use. These are carried out prior to the release of the medicine in the market.From:educationfundasViews:3 0ratingsTime:05:21More inEducation
Read this article:
How to Pronounce Caesar
Learn how to say Caesar correctly with EmmaSaying #39;s "how do you pronounce" free tutorials. Definition of Caesar (oxford dictionary): noun 1a title of Roman emperors, especially those from Augustus to Hadrian. an autocrat: they complained that he was behaving like a Caesar 2 Medicine, British informal a caesarean section. Phrases Caesar #39;s wife a person who is required to be above suspicion. [with reference to Plutarch #39;s Caesar ( x. 6) #39;I thought my wife ought not even to be under suspicion #39;] Origin: Middle English: from Latin Caesar, family name of the Roman statesman Julius Caesar, Gaius http://www.emmasaying.comFrom:Emma SayingViews:0 0ratingsTime:00:11More inHowto Style
Go here to read the rest:
Kp3 BeatBox
kaoss pad 3 beatbox bad medicine freestyle dnbFrom:snejdjxdndjViews:0 0ratingsTime:05:09More inPeople Blogs
See the original post:
SURVIVAL 249 ........My Medicine......Cover
From:Kirsty WhiteViews:0 0ratingsTime:03:10More inMusic
Read the original here:
Fake doctor gives child with expired medicine and plunges him into death
To get the latest news updates in Bhojpuri subscribe to Mahuaanewstv: http://www.youtube.comFrom:M MahuaanewsViews:0 0ratingsTime:04:28More inNews Politics
See original here:
Fake doctor gives child with expired medicine and plunges him into death - Video
Family In Need: Low Income Family Help For Free Medicine
Family In Need @ patientassistanceprogramsofamerica.com Low Income Family Help Is Available For Free Medicine With Patient Assistance Programs Is Your Family In Need Of Expensive Prescription Medications, But You Cannot Afford Them? Spend The Next 2 Minutes Learning About Low Income Family Help For Free Medicine Would Free Medicine Help Keep Your Family Healthy? Put A Smile On Your Face When You Can Keep Your Family Healthy If You Meet Any Of These 3 Criteria, You May Qualify Uninsured Underinsured No Drug Coverage US Drug Companies Have Patient Assistance Programs To Help Needy Families And You Don #39;t Need To Pay High Monthly Fees Either You #39;re Only A Click Away From Your Doctor Prescribed Meds When You Click On That Link Below This Video In The Description Box, You Can Start Saving Hundreds And Even Thousands Of Dollars In Free Medicine Website: patientassistanceprogramsofamerica.com YouTube Channel MedicineHelpUSA YouTube Channel URL: http://www.youtube.com YouTube URL: http://www.youtube.com Twitter: twitter.comFrom:MedicineHelpUSAViews:3 0ratingsTime:02:25More inScience Technology
View original post here:
Family In Need: Low Income Family Help For Free Medicine - Video
miracle and medicine in al-tariqa al-kasnazaniyah
In the name of Allah, the Most Beneficent, the Most Merciful In this preview, Dr. Khudhir Ahmed giving a brief explanation about the relation between the medical side and the religion in Al-Tariqa Al-Alia Al-Qadiriya Al-Kasnazaniyah , he will discuss some serious hits that some disciples and dervishes doing .From:ALkasnazanViews:1 0ratingsTime:06:14More inPeople Blogs
See the rest here:
Public release date: 6-Nov-2012 [ | E-mail | Share ]
Contact: Michael Bernstein m_bernstein@acs.org 202-872-6042 American Chemical Society
WASHINGTON, Nov. 6, 2012 Personalized medicine the promise of customizing treatments that will work best for each individual patient could get a boost from advances in understanding how the proteins that help determine health and disease take the three-dimensional shapes needed to work in the body. That's the message of the latest episode of the 2012 edition of a popular video series from the American Chemical Society (ACS), the world's largest scientific society. The videos are available at http://www.acs.org/PrizedScience and on DVD.
Titled Prized Science: How the Science Behind American Chemical Society Awards Impacts Your Life, the final episode of the 2012 series features the research of Peter Wolynes, Ph.D., winner of the 2012 ACS Award in Theoretical Chemistry. The award is sponsored by Dell Incorporated. Wolynes is a professor at Rice University.
The award recognizes Wolynes' research on proteins, those workhorses of human cells that carry out the instructions from the genetic material DNA. His research aims to help scientists understand how proteins fold into the correct architecture to keep the body healthy and functioning properly. When proteins do not take the right shape, illnesses, such as Alzheimer's disease, can develop. Even slight changes in a protein can have major effects on health, and understanding how this happens could help in the development of personalized medicine.
The premiere episode of Prized Science features Robert Langer, Sc.D., winner of the 2012 ACS Priestley Medal. The video explains Langer's pioneering work making body tissues in the lab by growing cells on special pieces of plastic. Langer's team has used the approach to make skin for burn patients, for instance, with the goal of eventually making whole organs for transplantation.
Other episodes feature Chad Mirkin, Ph.D., winner of the 2012 ACS Award for Creative Invention; Vicki Grassian, Ph.D., winner of the 2012 ACS Award for Creative Advances in Environmental Science and Technology; and Diane Bunce, Ph.D., winner of the 2012 ACS George C. Pimentel Award in Chemical Education.
ACS encourages educators, schools, museums, science centers, news organizations and others to embed links to Prized Science on their websites. The videos discuss scientific research in non-technical language for general audiences. New episodes in the series, which focuses on ACS' 2012 national award recipients, will be issued periodically.
The 2012 edition of Prized Science is completely refreshed, with a new look and feel, with renowned scientists telling the story of their own research and its impact and potential impact on everyday life. Colorful graphics and images visually explain the award recipient's research.
###
Go here to read the rest:
Personalizing medicine: New American Chemical Society Prized Science video
LOS ANGELES Lance Becker, MD, a professor of Emergency Medicine and director of the Center for Resuscitation Science at the Perelman School of Medicine at the University of Pennsylvania, will receive the American Heart Associations 2012 Award for Lifetime Achievement in Cardiac Resuscitation Science during the organizations annual Scientific Sessions.
Dr. Becker is board certified in internal medicine, emergency medicine and critical care medicine, and during his career has played key roles in the dissemination of automated external defibrillators into the public arena, expanding the science of CPR quality, and developing a resuscitation training program. His research interests extend across the basic science laboratory from animal models of resuscitation into human therapies such as novel methods of therapeutic hypothermia induction and the use of cardiac bypass following cardiac arrest. His cellular studies have helped define cellular reperfusion injury mechanisms, mitochondrial oxidant generation, reactive oxygen and nitrogen species responses to ischemia, apoptotic activation following ischemia, signaling pathways and new cellular cytoprotective strategies.
He has held numerous leadership posts within the American Heart Association, and he helped create the organizations Resuscitation Science Symposium, the leading international venue for the presentation of cutting-edge science in resuscitation. Dr. Becker has worked closely with the NIH as a reviewer and grantee, and as a leader for National Heart Lung and Blood Institute initiatives supporting research funding in resuscitation research. He also served as a member of the Food and Drug Administration Device Evaluation panels and has appeared before the FDA panels as an expert presenter. He is an elected member of the Institute of Medicine of the National Academies.
###
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
Continued here:
LOS ANGELES Daniel J. Rader, MD, professor of Medicine and chief, Division of Translational Medicine and Human Genetics, at the Perelman School of Medicine at the University of Pennsylvania, has been awarded the American Heart Associations (AHA) Clinical Research Prize for developing new methods to identify factors regulating the metabolism of fat particles in the bloodstream and testing their impact on the development of atherosclerosis. Dr. Rader received the award today during the opening ceremony of the AHA Scientific Sessions in Los Angeles, CA.
Dr. Rader has spent the last two decades working in the field of lipoprotein biology and atherosclerosis, and is a widely recognized international leader in this field. His basic research laboratory focuses on genetic and pharmacologic regulation of lipoprotein metabolism and atherosclerosis, and he directs a translational research program focusing on new pathways involved in lipoprotein metabolism and atherosclerosis discovered through human genetics studies and novel approaches to treatment of dyslipidemia and atherosclerotic cardiovascular disease.
Dr. Rader has a particular interest in the metabolism of HDL (the good cholesterol) and its relationship to atherosclerosis. In recent research, he has illuminated pathways of HDL-mediated reverse cholesterol transport and has shown that the functional ability of HDL to extract cholesterol from cells is a better predictor of coronary disease than HDL cholesterol blood levels. In addition, Rader and his team have helped to understand how new genes associated with dyslipidemia and coronary artery disease work to influence these conditions. Finally, Rader and his team demonstrated the potential usefulness of a drug that works through a new pathway to lower LDL (the bad cholesterol) in patients with a severe form of inherited high cholesterol.
He is a Distinguished Fellow of the International Atherosclerosis Society, a member of the Board of External Experts of the National Heart, Lung, and Blood Institute (NHLBI), and a member of the Institute of Medicine.
###
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
Read more:
Penn Medicine's Daniel J. Rader, MD, Receives American Heart Association's Clinical Research Prize
Public release date: 4-Nov-2012 [ | E-mail | Share ]
Contact: Jessica Mikulski jessica.mikulski@uphs.upenn.edu 215-796-4829 University of Pennsylvania School of Medicine
LOS ANGELES - Daniel J. Rader, MD, professor of Medicine and chief, Division of Translational Medicine and Human Genetics at the Perelman School of Medicine at the University of Pennsylvania, has been awarded the American Heart Association's (AHA) Clinical Research Prize for developing new methods to identify factors regulating the metabolism of fat particles in the bloodstream and testing their impact on the development of atherosclerosis. Dr. Rader received the award today during the opening ceremony of the AHA Scientific Sessions in Los Angeles, CA.
Dr. Rader has spent the last two decades working in the field of lipoprotein biology and atherosclerosis, and is a widely recognized international leader in this field. His basic research laboratory focuses on genetic and pharmacologic regulation of lipoprotein metabolism and atherosclerosis, and he directs a translational research program focusing on new pathways involved in lipoprotein metabolism and atherosclerosis discovered through human genetics studies and novel approaches to treatment of dyslipidemia and atherosclerotic cardiovascular disease.
Dr. Rader has a particular interest in the metabolism of HDL (the "good cholesterol") and its relationship to atherosclerosis. In recent research, he has illuminated pathways of HDL-mediated 'reverse cholesterol transport' and has shown that the functional ability of HDL to extract cholesterol from cells is a better predictor of coronary disease than HDL cholesterol blood levels. In addition, Rader and his team have helped to understand how new genes associated with dyslipidemia and coronary artery disease work to influence these conditions. Finally, Rader and his team demonstrated the potential usefulness of a drug that works through a new pathway to lower LDL (the "bad cholesterol") in patients with a severe form of inherited high cholesterol.
He is a Distinguished Fellow of the International Atherosclerosis Society, a member of the Board of External Experts of the National Heart, Lung, and Blood Institute (NHLBI), and a member of the Institute of Medicine.
###
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
See original here:
Penn Medicine's Daniel J. Rader, M.D., receives AHA's Clinical Research Prize
HOUSTON, TX--(Marketwire - Nov 6, 2012) - Dr. Scott Rand, board certified primary care sports medicine physician at The Methodist Center for Orthopedic Surgery & Sports Medicine, has carved a unique niche on the Methodist Willowbrook Hospital campus -- with a "whole patient" approach to athletes and active people of all ages and abilities.
Dr. Rand, who recently co-authored and coedited the AMSSM (American Medical Society for Sports Medicine) Sports Medicine CAQ (Certificate of Added Qualifications) Study Guide, is redefining family and sports medicine with his Sports Health program within the primary care sports medicine practice.
Primary Care Sports Medicine specialists are physicians with a primary certification in Family Practice, Internal Medicine, Emergency Medicine, Pediatrics or Physical Medicine and Rehabilitation-- who undergo sports medicine training in a recognized subspecialty fellowship program.
According to Dr. Rand, focusing on the whole patient, Sports Health at Methodist Willowbrook works collaboratively with its orthopedic partners, licensed athletic trainers and team coaches to ensure optimal performance through optimal health -- with special emphasis on overuse conditions, concussion management, and medical care focused on active people.
"We are the complete 'healthcare home' to athletes in our community.We assess the overall patient and address the health challenges keeping them from their full potential physically," said Dr. Scott Rand.
"We also focus on overuse injuries and conditions, as well as proper training and nutrition for a rapid and safe return to sports following an injury," he added.
Rand, who is an avid speaker and educator at national conferences and continuing education programs -- recently participating in the AMSSM 21st Annual Conference in Atlanta and The Athlete and the Brain - Where Sports Medicine and Psychology Meet in Houston.
Located within the Methodist Center for Orthopaedic Surgery & Sports Medicine, the Sports Health resources include expansive running and throwing lanes for athletic evaluations and post injury conditioning, physical and occupational therapies, rehabilitation services, concussion management using computerized neurocognitive testing -- and a cutting edge human performance lab providing endurance athletes with a tailored training prescription based on their individual VO2 max results, as well as provide bariatric patients with Resting Metabolic Rate (RMR) testing and consultation for sustained weight loss.
Expanding its NW Houston campus, Methodist Willowbrook Hospital has received its chest pain and stroke accreditations, performs complex surgeries such as neurosurgery and open heart, boasts a state-of-the-art orthopedic, sports medicine and rehabilitation center and focuses on women and children in its new Women's & Children's Pavilion.
For more information on the sports physicals or weekend sports injury clinics call 281.737.2120.To take a facility tour, learn more about the primary care sports medicine physicians and the Sports Health program, or check dates for upcoming seminars, sports clinics and health fairs go to http://www.methodistwillowbrookortho.com, or call 281.737.0999.Human Performance lab appointments call 281.737.0466.
Read more from the original source:
NEW YORK, Nov. 6, 2012 /PRNewswire/ -- The physicians of Reproductive Medicine Associates of New York (RMA of New York) are proud to support The American Society for Reproductive Medicine (ASRM) in their recent decision to lift oocyte cryopreservation from its previous "experimental" label.Analyzing over 1,000 relevant research papers, ASRM has concluded that the rates of implantation and pregnancy using frozen eggs are similar to those of fresh eggs; in light of their findings, the researchers of ASRM have concluded that oocyte cryopreservation can no longer be considered an experimental treatment.
"This is beyond exciting, as it opens numerous doors for women in terms of future fertility," says Dr. Alan Copperman, Co-Medical Director of RMA of New York. "With egg freezing now becoming a main stream reproductive option, we can now offer the treatment and deliver hope to even more women."
Oocyte cryopreservation, more commonly known as egg freezing, is the process of extracting, freezing and storing a woman's eggs, typically for the purpose of safeguarding child-rearing options for a later time. The physicians of RMA of New York attribute the success of their egg freezing program to their state of the art laboratory and the highly specialized freezing technique called oocyte vitrification, a process of rapid-freezing that prevents ice crystals from forming within the oocyte and appears to improve oocyte survival rates.
There are numerous situations in which freezing eggs may be beneficial for women.RMA of New York offers egg freezing to those at risk of becoming sterile due to chemotherapy, radiotherapy or removal of their ovaries.In addition, the scientific team at RMA of NY is performing research to determine whether a woman is at risk of early menopause and to assess who could potentially most benefit from the technology.
About Reproductive Medicine Associates of New York (RMA of New York)
RMA of New York is the Reproductive Endocrinology and Infertility division of Mount Sinai Medical Center in New York City and has been caring for patients in its midtown Manhattan location since 2001, with additional locations in Westchester, Long Island, and Brooklyn, New York. RMA of New York is a full-service fertility center, specializing in in vitro fertilization (IVF), egg donation, egg freezing, reproductive surgeries and male reproductive medicine. Highly individualized patient care is offered through ten reproductive endocrinologists, a urologist, a complementary care team and highly qualified staff. For more information, please call 212.756.5777 or visit http://www.rmany.com.
View post:
WALTHAM, Mass. and LOS ANGELES, Nov. 5, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that it will be launching a major initiative to help hospitals reduce the number of unplanned readmissions for heart failure patients, beginning at the American Heart Association (AHA) Scientific Sessions 2012 taking place Nov. 3-7, 2012 in Los Angeles, California. Representatives at the BG Medicine booth (#1737) will be on hand to highlight the role that galectin-3 blood testing can play in helping hospitals address the urgent need to reduce readmission rates.
Since taking effect on October 1, 2012, new rules from the federal Centers for Medicare & Medicaid Services (CMS) have made reducing unplanned hospital readmissions a critical priority. Hospitals that exceed the Medicare thresholds will be assessed financial penalties that are expected to reach an aggregate of nearly $300 million this year alone, and nearly $1 billion by 2015, if improvements are not made.
Even with optimal care, today nearly a quarter of all Medicare heart failure patients are readmitted to the hospital within 30 days1, making heart failure a major driver of hospital readmission rates, far ahead of myocardial infarction and pneumonia. Because heart failure patients with elevated galectin-3 are two-to-three times more likely to be readmitted to the hospital within 30 days of discharge, identifying these high-risk patients through galectin-3 testing is a potentially valuable and cost-effective tool in a hospital's strategy to reduce unplanned 30-day readmissions. Identifying those at greater risk with galectin-3 testing enables hospitals to better direct their intervention strategies and resources to those who need them most, potentially providing a way to improve outcomes while also controlling costs and avoiding penalties.
"Patient stratification tools that help predict risk of near-term readmission would allow the clinician to better direct more resource-intensive heart failure disease management efforts to patients at higher risk," said Rudolf A. de Boer, MD, PhD, Associate Professor of Cardiology at the University Medical Center Groningen in the Netherlands. "Such tools would be usable upon discharge, with a simple interpretation such as a single threshold value. Galectin-3 is such a tool and should be considered for heart failure readmissions programs. Baseline galectin-3 is a powerful predictor of unplanned hospital readmissions and, importantly, adds significantly to other risk factors such as age, reduced renal function, diminished left ventricular pumping capacity and BNP levels."
The BG Medicine booth at AHA will include an interactive demonstration that will enable health care professionals and hospital administrators to determine the financial impact of utilizing galectin-3 testing at their hospitals as part of a comprehensive readmissions reduction strategy. The BG Medicine Galectin-3 Readmissions Calculator being introduced at AHA will enable users to determine the potential financial impact of galectin-3 testing instantly, factoring in the costs of testing and of implementing a targeted intervention initiative, as well as the reduction in costs associated with lower readmissions and avoidance of Medicare penalties.
"Galectin-3 testing is a powerful tool for those seeking to make their intervention strategies on patients with clinical variations more targeted, efficient and effective," said Eric Bouvier, President and CEO of BG Medicine. "We look forward to expanding our efforts to help health professionals address this urgent issue."
The BGM Galectin-3(R) Test is cleared by the FDA as an aid in assessing the prognosis of patients with chronic heart failure.
About Galectin-3 and Heart Failure
Galectin-3 is a unique carbohydrate-binding lectin, or protein, that binds to carbohydrates called beta-galactosides. Galectin-3 has been implicated in a variety of biological processes important in the development and progression of heart failure, and is believed to be a primary mediator of progressive cardiac fibrosis (abnormal thickening and stiffening of the heart muscle) and adverse remodeling (changes in the structure of the heart). Higher levels of galectin-3 are associated with a more aggressive form of heart failure and 30% or more of mild to moderate heart failure patients will have elevated levels of galectin-3. Heart failure affects an estimated 5.8 million Americans, with approximately 670,000 new cases occurring each year. The direct and indirect cost of heart failure in the United States for 2010 is estimated to be $39.2 billion.
About BG Medicine, Inc.
View post:
Family of Family Medicine Now Under One Roof in Washington
Family medicine has long had a presence in Washington. The AAFP, the AAFP's Robert Graham Center, the American Board of Family Medicine and the Council of Academic Family Medicine -- which represents the Association of Departments of Family Medicine, the Association of Family Medicine Residency Directors, the North American Primary Care Research Group and the Society of Teachers of Family Medicine -- all have had offices in our nation's capital.
Now, for the first time, you can find representatives of all those organizations under one roof.
The Academy and its sister organizations recently moved into a new location that not only brings us together but also brings us closer to the White House and Congress. These groups, which are so interconnected, now will be working together in the same place.
In this era of e-mail, texting and smartphones, communication has never been easier. But there still is something to be said for face-to-face meetings. If one of the family medicine organizations has a question about what the other is doing or needs input, staff can simply walk down the hall. Meetings will be easier to schedule. Communication will be enhanced, and our work will be more efficient.
I got a first-hand look at the new offices Oct. 31 and Nov. 1 when AAFP leaders were in Washington to meet with White House and congressional staff as well as other key stakeholders, for conversations about Medicare physician payment, workforce issues, veterans' health care and health research.
The AAFP already had close working relationships with the other family medicine organizations, but that might not have been clear to outsiders. It should be obvious now to anyone who walks through our doors.
And plenty of people did just that last week, including AAFP member Alma Littles, M.D., of Tallahassee, Fla., who is pictured with me here. Academy leaders and staff met with representatives from the AARP, the Agency for Healthcare Research and Quality, and the Bipartisan Policy Center in the new Washington AAFP board room. And representatives from CMS and other health care stakeholders attended our open house.
Advocacy has always been a key part of our mission, but having all our organizations represented in one location makes it clear that we mean business in Washington. It also illustrates the growing visibility and impact of family medicine on Capitol Hill and among federal agencies.
Reid Blackwelder, M.D., is President-elect of the AAFP.
See the article here:
Weather Modification, Technetronic Warfare -- Dr. Nick Begich
Alex talks with Dr. Nick Begich, co-author of Angels Don #39;t Play This HAARP: Advances in Tesla Technology. Begich has pursued independent research in the sciences and politics for most of his adult life. He received Doctor of Medicine (Medicina Alternitiva), honoris causa, for independent work in health and political science, from The Open International University for Complementary Medicines, Colombo, Sri Lanka, in November 1994. Begich has served as an expert witness and speaker before the European Parliament. He has spoken on various issues for groups representing citizen concerns, statesmen and elected officials, scientists and others. Begich is also the author of Earth Rising II: The Betrayal of Science, Society and the Soul with the late James Roderick, and Controlling the Human Mind: The Technologies of Political Control or Tools for Peak Performance. Begich #39;s books and his DVD, Angels Still Don #39;t Play This HAARP, are available at the Infowars store. Alex also covers the news and takes your calls. http://www.earthpulse.com http://www.infowars.com http://www.prisonplanet.tvFrom:LibertyTruthJusticeViews:1 0ratingsTime:36:30More inEducation
See the original post here:
Weather Modification, Technetronic Warfare -- Dr. Nick Begich - Video
Where to buy Diazepam online Europe US Canada UK Australia
http://www.medstore-online.com Diazepam is in a group of drugs called benzodiazepines. Diazepam affects chemicals in the brain that may become unbalanced and cause anxiety. Diazepam is used to treat anxiety disorders, alcohol withdrawal symptoms, or muscle spasms. It is sometimes used with other medications to treat seizures. Diazepam may also be used for purposes not listed in this medication guide. Important information about diazepam You should not use this medication if you are allergic to diazepam or similar medicines (Ativan, Klonopin, Restoril, Xanax, and others), or if you have myasthenia gravis, severe liver disease, narrow-angle glaucoma, a severe breathing problem, or sleep apnea. Do not use diazepam if you are pregnant. It could harm the unborn baby. Before you take diazepam, tell your doctor if you have glaucoma, asthma or other breathing problems, kidney or liver disease, seizures, or a history of drug or alcohol addiction, mental illness, depression, or suicidal thoughts. Do not drink alcohol while taking diazepam. This medicine can increase the effects of alcohol. Never take more of this medication than your doctor has prescribed. An overdose of diazepam can be fatal. Diazepam may be habit-forming and should be used only by the person it was prescribed for. Keep the medication in a secure place where others cannot get to it. Diazepam may be habit forming and should be used only by the person it was prescribed for. Never share diazepam with another person ...From:gary jeffersViews:0 0ratingsTime:01:09More inEducation
Read the original post:
Where to buy Diazepam online Europe US Canada UK Australia - Video